T0	Interventions 341 511	tamoxifen and to assess the therapeutic advantage of sequentially adding low-dose cyclophosphamide-methotrexate-5-fluorouracil (CMF) chemotherapy in tamoxifen responders.
T1	Interventions 610 625	tamoxifen alone